| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |